Literature DB >> 10216477

K-ras and p53 mutations and overexpressions as prognostic factors in female rectal carcinoma.

P Hirvikoski1, A Auvinen, K Servomaa, A Kiuru, T Rytömaa, K Makkonen, V M Kosma.   

Abstract

BACKGROUND: The present study was undertaken to determine the prognostic significance of K-ras, p53 and bcl-2 in female rectal carcinoma.
MATERIALS AND METHODS: The mutations in K-ras and p53 genes were analysed using SSCP and direct sequencing. The expression of K-ras, bcl-2 and p53 proteins was determined immunohistochemically.
RESULTS: Mutations of K-ras and p53 genes were detected in 12% and 38% of the tumours, respectively. The prevalence of K-ras overexpression was 67%. K-ras mutations were not associated with survival. However, more favourable survival was observed for patients with K-ras overexpression than with normal expression (adjusted hazard ratio from Cox model 0.4, 95% CI 0.2-0.8). Mutation or overexpression of p53 were not associated with survival.
CONCLUSIONS: It may be possible, that the mutations and protein overexpression of K-ras and p53 in female rectal carcinoma have different clinical impact on patient survival as suggested in previous studies concerning colorectal carcinoma of both sexes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10216477

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  The status of targeted agents in the setting of neoadjuvant radiation therapy in locally advanced rectal cancers.

Authors:  Rob Glynne-Jones; Maher Hadaki; Mark Harrison
Journal:  J Gastrointest Oncol       Date:  2013-09

2.  p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women.

Authors:  K Servomaa; A Kiuru; V M Kosma; P Hirvikoski; T Rytömaa
Journal:  Mol Pathol       Date:  2000-02

Review 3.  High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis.

Authors:  Qi Huang; Shu Li; Pu Cheng; Mei Deng; Xin He; Zhen Wang; Cheng-Hui Yang; Xiao-Ying Zhao; Jian Huang
Journal:  World J Gastroenterol       Date:  2017-07-21       Impact factor: 5.742

4.  Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer.

Authors:  Shuang Bai; Qiang Feng; Xin-Yan Pan; Hong Zou; Hao-Bin Chen; Peng Wang; Xin-Liang Zhou; Yan-Ling Hong; Shu-Ling Song; Ju-Lun Yang
Journal:  Int J Mol Med       Date:  2017-02-21       Impact factor: 4.101

Review 5.  Prognostic value of KRAS codon 13 gene mutation for overall survival in colorectal cancer: Direct and indirect comparison meta-analysis.

Authors:  Min Seob Kwak; Jae Myung Cha; Jin Young Yoon; Jung Won Jeon; Hyun Phil Shin; Hye Jung Chang; Hyung Kyung Kim; Kwang Ro Joo; Joung Il Lee
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.